Biomarkers in Pulsed Field Ablation Versus Cryoballoon Ablation

NCT05862038 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-05-19

No results posted yet for this study

Summary

Our study will include consecutive patients undergoing pulsed field ablation (PFA) or cryoballoon (CBA) ablation. Tissue injury and inflammation markers will be measured before and after the procedure.

Conditions

Sponsors & Collaborators

  • Ana Jordan

    lead OTHER

Principal Investigators

  • Ana Jordan · University Hospital Dubrava

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2024-07-10
Completion
2024-09-10

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862038 on ClinicalTrials.gov